FLVCR2 and breast cancer: This study has demonstrated that treatment of breast cancer cells with metformin is associated with modifications in the activity of the enzymes choline kinase, CCT and PtdCho-PLC with corresponding changes in the incorporation of choline into Pcho and PtdCho.